Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameHygeia Health
Stock Code06078
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities以腫瘤科為核心的醫療集團,主要經營自有民營營利性醫院並提供腫瘤醫療服務及其他醫療服務;提供放療中心諮詢服務、專利立體定向放療設備授權及維護和技術支持服務;以及管理民營非營利性醫院並收取管理費。
Listing Date2020-06-29
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國上海市靜安區梅園路228號企業廣場702-707室
Business Address (Hong Kong)香港灣仔皇后大道東248號陽光中心40樓
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitewww.hygeia-group.com.cn
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 18.50 / shares
Offer Price RangeFinal offer price only, no range
Lot Size200 shares
Entry ThresholdHK$ 3,700
Par ValueTo be extracted
Offer Period2020-06-16 to 2020-06-19
Global Offering Shares120,000,000 shares
HK Public Offer Shares (Initial)12,000,000 shares (10.0%)
Public Offer Lots (Initial)60,000lots (Pool A30,000lots,Pool B30,000lots)
International Placing Shares (Initial)108,000,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO600,000,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share49.9%
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 2,220,000,000

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 200 HK$ 3,700
2 lots 400 HK$ 7,400
3 lots 600 HK$ 11,100
4 lots 800 HK$ 14,800
5 lots 1,000 HK$ 18,500
6 lots 1,200 HK$ 22,200
7 lots 1,400 HK$ 25,900
8 lots 1,600 HK$ 29,600
9 lots 1,800 HK$ 33,300
10 lots 2,000 HK$ 37,000
15 lots 3,000 HK$ 55,500
20 lots 4,000 HK$ 74,000
25 lots 5,000 HK$ 92,500
30 lots 6,000 HK$ 111,000
35 lots 7,000 HK$ 129,500
40 lots 8,000 HK$ 148,000
45 lots 9,000 HK$ 166,500
50 lots 10,000 HK$ 185,000
100 lots 20,000 HK$ 370,000
150 lots 30,000 HK$ 555,000
200 lots 40,000 HK$ 740,000
250 lots 50,000 HK$ 925,000
300 lots 60,000 HK$ 1,110,000
350 lots 70,000 HK$ 1,295,000
400 lots 80,000 HK$ 1,480,000
450 lots 90,000 HK$ 1,665,000
500 lots 100,000 HK$ 1,850,000
1,000 lots 200,000 HK$ 3,700,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1,500 lots 300,000 HK$ 5,550,000
2,000 lots 400,000 HK$ 7,400,000
2,500 lots 500,000 HK$ 9,250,000
3,000 lots 600,000 HK$ 11,100,000
3,500 lots 700,000 HK$ 12,950,000
4,000 lots 800,000 HK$ 14,800,000
4,500 lots 900,000 HK$ 16,650,000
5,000 lots 1,000,000 HK$ 18,500,000
10,000 lots 2,000,000 HK$ 37,000,000
15,000 lots 3,000,000 HK$ 55,500,000
20,000 lots 4,000,000 HK$ 74,000,000
25,000 lots 5,000,000 HK$ 92,500,000
30,000 lots 6,000,000 HK$ 111,000,000

Stock Connect Inclusion Analysis

HK Market Cap HK$ 6.59B
Analysis Result Already included in Stock Connect (both)

Valuation & Financials

Market Cap (at Offer Price)HK$ 10,650,000,000
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約人民幣39.8百萬元
Period-End Cash Balance人民幣393.4百萬元
Listing Expenses~HK$ 144,200,000
Listing Expenses / Funds Raised~6.5%
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Income Statement
Item 201720182019
Revenue 596,480766,1421,085,826
Cost of sales -427,172-527,407-755,706
Gross profit 169,308238,735330,120
Other income and gains, net 3,7724,1504,895
Selling and distribution expenses -34,713-32,781-15,419
Administrative expenses -97,504-101,574-136,272
Operating profit 48,387105,542174,207
Net finance costs -73,126-78,279-94,887
Profit before tax -24,73927,26379,320
Income tax expense -21,771-24,845-39,553
Profit for the year -46,5102,41839,767
Profit attributable to owners -46,4342,58839,767
Balance Sheet
Item 201720182019
Cash and cash equivalents 280,660190,552393,409
Trade and bills receivables 152,177225,068224,936
Inventories 35,33041,01747,016
Total current assets 562,118513,104668,530
Total assets 1,783,5921,982,4902,213,189
Total current liabilities 393,004415,4461,714,181
Total liabilities 2,086,4552,170,7342,415,795
Total equity -302,863-188,244-202,606
Equity attributable to owners -306,655-191,866-202,606
Interest-bearing borrowings 66,00056,0000
Cash Flow Statement
Item 201720182019
Net cash from operating activities 66,825159,941228,617
Net cash from investing activities 84,198-262,462-134,978
Net cash from financing activities -47,30112,397104,562
Net increase in cash 103,722-90,124198,201
Purchase of PP&E -229,285-287,647-154,245
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 26.0
First Day OpenHK$ 22.8
First Day Change40.54%
First Day Volume78681000.0
First Day Turnover1913350000.0
Use of Proceeds
1、約60%(或1,243.3百萬港元)將用于單縣海吉亞醫院、重慶海吉亞醫院及成武海吉亞醫院(均屬我們的自有營利性醫院)的升級,并在聊城、德州、蘇州及龍巖市設立新醫院; 2、約30%(或621.7百萬港元)將用于合適機遇到來時,在人口龐大、對腫瘤醫療服務需求相對較高的新市場中收購醫院; 3、約5%(或103.6百萬港元)將用于升級信息技術系統; 4、約5%(或103.6百萬港元)將用于營運資金及其他一般企業用途。

Underwriting Syndicate

Joint Sponsors (2)
Morgan Stanley Asia Limited CE AAD291 海通国际资本有限公司 CE ADQ859
Overall Coordinators (3)
Morgan Stanley Asia Limited CE AAD291 海通国际证券有限公司 CE AAF806 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809
Joint Bookrunners (3)
Morgan Stanley Asia Limited CE AAD291 海通国际证券有限公司 CE AAF806 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809
Joint Lead Managers (3)
Morgan Stanley Asia Limited CE AAD291 海通国际证券有限公司 CE AAF806 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Foresight Orient Global Superior Choice SPC 38,746,400 HKD — 1.75% — 6 months 2020-12-29
2 Golden Valley Global Limited 38,746,400 HKD — 1.75% — 6 months 2020-12-29
3 Hillhouse Funds 387,493,600 HKD — 17.45% — 6 months 2020-12-29
4 Hudson Bay Master Fund LTD 77,496,500 HKD — 3.49% — 6 months 2020-12-29
5 Lake Bleu Prime Healthcare Master Fund Limited 92,995,800 HKD — 4.19% — 6 months 2020-12-29
6 OrbiMed Funds 154,996,700 HKD — 6.98% — 6 months 2020-12-29
7 Sage Partners Master Fund 77,496,500 HKD — 3.49% — 6 months 2020-12-29
8 Tiger Pacific Master Fund LP 123,998,100 HKD — 5.59% — 6 months 2020-12-29
9 南方基金管理股份有限公司 116,246,600 HKD — 5.24% — 6 months 2020-12-29

Directors & Management

PositionChinese nameEnglish Name
Chairman方敏—
Company Secretary任愛、楊靜文—
No director data available.

Major Shareholders

Major Shareholders & Holdings朱先生及朱女士一致行動人士透過Century River、Red Palm及Amber Tree持有約46.46%股權;Fountain Grass持有約13.79%;Harmony Healthcare持有約6.20%。
About this page

This page shows Hygeia Health (06078) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect